These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2208617)

  • 1. Synergistic inhibition of platelet aggregation by fibrinogen-related peptides.
    Adelman B; Gennings C; Strony J; Hanners E
    Circ Res; 1990 Oct; 67(4):941-7. PubMed ID: 2208617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
    Foster MR; Hornby EJ; Brown S; Kitchin J; Hann M; Ward P
    Thromb Res; 1993 Nov; 72(3):231-45. PubMed ID: 8303662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin.
    Gartner TK; Taylor DB
    Proc Soc Exp Biol Med; 1991 Oct; 198(1):649-55. PubMed ID: 1716370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
    J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Gartner TK; Bennett JS
    J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity.
    Knapp A; Degenhardt T; Dodt J
    J Biol Chem; 1992 Dec; 267(34):24230-4. PubMed ID: 1447173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide.
    Ugen KE; Mahalingam M; Klein PA; Kao KJ
    J Natl Cancer Inst; 1988 Nov; 80(18):1461-6. PubMed ID: 3184195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
    Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
    Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
    Chiang HS; Yang RS; Huang TF
    Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-dependent vasorelaxant and anti-aggregatory effect and mechanism of action of some antifibrinogen RGD (Arg-Gly-Asp-containing) peptides.
    Torday LL; Pataricza J; Balogh GE; Zarándi M; Penke B; Papp JG
    J Pharm Pharmacol; 1998 Jun; 50(6):667-71. PubMed ID: 9680079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro fibrinolysis and antithrombosis characterizations of novel recombinant microplasminogen with RGD and GPRP peptides.
    Chen W; Li Y; Chen P; Wu M; Wang L; Zhang H; Wang L
    J Thromb Thrombolysis; 2016 Jul; 42(1):118-26. PubMed ID: 26814674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
    Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.
    Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
    Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
    Huang TF; Wang WJ; Teng CM; Ouyang C
    Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet retention on artificial microvascular grafts with monoclonal antibodies and a high-affinity peptide directed against platelet membrane glycoproteins.
    Johnson PC; Sheppeck RA; Hribar SR; Bentz ML; Janosky J; Dickson CS
    Arterioscler Thromb; 1991; 11(3):552-60. PubMed ID: 1709360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.